Mudabpil, Bairosma M.

HRN: 22-28-64  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/03/2022
AMPICILLIN 250MG (VIAL)
12/03/2022
12/09/2022
IVT
275 Mg
Q6
URTI
Waiting Final Action 
12/04/2022
MEBENDAZOLE 100MG/5ML, 60ML SUSPENSION
12/04/2022
12/06/2022
PO
5ml
BID
Ascariasis
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: